These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1329211)

  • 1. Ifosfamide in non-small cell lung cancer: a review.
    Eberhardt W; Niederle N
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):40-8. PubMed ID: 1329211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide in the treatment of non-small cell lung cancer.
    Ettinger DS
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):31-8. PubMed ID: 2539646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.
    Masters GA; Hoffman PC; Drinkard LC; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):8-14. PubMed ID: 9535205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European experience with ifosfamide in non-small cell lung cancer.
    Drings P
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):22-30. PubMed ID: 2539645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifosfamide-based three-drug combination regimens in non-small cell lung cancer.
    Vokes EE; Masters GA; Mauer AM; Hoffman PC; Watson S; Golomb HM
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):19-22. PubMed ID: 9535207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide in non-small cell lung cancer.
    Johnson DH
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):7-10. PubMed ID: 8677453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.
    Crawford J; George M
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):18-22. PubMed ID: 7541916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer.
    Shepherd FA; Latreille J; Paul K; Eisenhauer E
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):84-90. PubMed ID: 9007130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
    Hoffman PC; Masters GA; Drinkard LC; Krauss SA; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):11-5. PubMed ID: 8677441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer.
    Chang AY; Asbury RF; Boros L; Garrow GC; Hsieh S
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):9-12. PubMed ID: 7610399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide and paclitaxel combinations for the treatment of advanced non-small cell lung cancer.
    Shepherd FA; Eisenhauer E
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):2-7. PubMed ID: 9535204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago.
    Vokes EE; Hoffman PC; Masters GA; Golomb HM; Drinkard LC; Krauss SA
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):15-8. PubMed ID: 8711496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.
    Lorusso V; Gebbia V; Spada M; Guida M; Cassano G; Brunetti C; Germano D; Nettis G; Izzi G; Galetta D; Giampaglia M; Silvestris N; Colucci G
    Oncol Rep; 2005 Dec; 14(6):1547-51. PubMed ID: 16273254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer.
    Perez EA; Gandara DR
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):2-5. PubMed ID: 8209273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.